Hepatic Subcapsular Flow as a Significant Diagnostic Marker for Biliary Atresia: A Meta-Analysis

Abstract EN

Aim.

Increasing evidence indicates that hepatic subcapsular flow (HSF) can serve as a noninvasive ultrasonographic marker for the early diagnosis of biliary atresia (BA).

However, results regarding its diagnostic accuracy are inconsistent and inconclusive.

We conducted this meta-analysis with an aim to systematically evaluate the diagnostic value of HSF in predicting BA.

Methods.

A comprehensive literature search of four databases was conducted to identify the eligible studies.

All analyses were performed using STATA 12.0.

Results.

Nine studies from eight articles containing 368 patients and 469 controls were included in our meta-analysis.

Briefly, the values for pooled sensitivity, specificity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR), and area under the curve (AUC) were 0.95 (95% CI 0.88-0.98), 0.92 (95% CI 0.85-0.96), 11.6 (95% CI 6.3-21.5), 0.06 (95% CI 0.02-0.14), 201 (95% CI 59-689), and 0.98 (95% CI 0.96-0.99), respectively.

Additionally, metaregression along with subgroup analysis based on various covariates revealed the potential sources of heterogeneity and the detailed diagnostic value in each subgroup.

Conclusion.

Our meta-analysis showed that HSF assay could provide high accuracy in predicting BA patients and non-BA individuals.

However, further studies with better design and larger sample size are required to support the results of the present study.